Hepatic encephalopathy following transjugular intrahepatic portosystemic shunt (TIPS): Management with l-ornithine-l-aspartate and stent reduction

被引：0
|
作者：
Vanessa Stadlbauer
Josef Tauss
Horst R. Portugaller
Philipp Stiegler
Florian Iberer
Rudolf E. Stauber
机构：
[1] Medical University of Graz,Department of Internal Medicine, Division of Gastroenterology and Hepatology
[2] Medical University of Graz,Department of Radiology, Division of Interventional Radiology
[3] Medical University of Graz,Department of Surgery, Division of Transplantation Surgery
[4] University College London,Department of Medicine, Liver Failure Group, UCL Institute of Hepatology
来源：
Metabolic Brain Disease | 2007年 / 22卷
关键词：
Hepatic encephalopathy; Venous ammonia levels; Transjugular intrahepatic portosystemic shunt; -ornithine-; -aspartate; Stent reduction;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Hepatic encephalopathy (HE) is a common problem after insertion of a trans-jugular intrahepatic portosystemic shunt (TIPS), which may be difficult to manage. We present a case of severe post-TIPS HE unresponsive to high doses of l-ornithine-l-aspartate (LOLA) despite reduction of venous ammonia levels in a dose-dependent fashion. Ultimately, high-grade HE was successfully treated by a reduction stent and the patient subsequently underwent successful liver transplantation.
引用
收藏
页码：45 / 50
页数：5
相关论文
共 50 条
  • [31] Targeted puncture of left branch of intrahepatic portal vein in transjugular intrahepatic portosystemic shunt to reduce hepatic encephalopathy
    Luo, Shi-Hua
    Chu, Jian-Guo
    Huang, He
    Zhao, Guo-Rui
    Yao, Ke-Chun
    WORLD JOURNAL OF GASTROENTEROLOGY, 2019, 25 (09) : 1088 - 1099
  • [32] Predictors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in cirrhotic patients: A systematic review
    Bai, Ming
    Qi, Xingshun
    Yang, Zhiping
    Yin, Zhanxin
    Nie, Yongzhan
    Yuan, Shanshan
    Wu, Kaichun
    Han, Guohong
    Fan, Daiming
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 (06) : 943 - 951
  • [33] Targeted puncture of left branch of intrahepatic portal vein in transjugular intrahepatic portosystemic shunt to reduce hepatic encephalopathy
    Shi-Hua Luo
    Jian-Guo Chu
    He Huang
    Guo-Rui Zhao
    Ke-Chun Yao
    World Journal of Gastroenterology, 2019, (09) : 1088 - 1099
  • [34] Incidence of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt (TIPS) according to its severity and temporal grading classification
    Paolo Fonio
    Andrea Discalzi
    Marco Calandri
    Andrea Doriguzzi Breatta
    Laura Bergamasco
    Silvia Martini
    Antonio Ottobrelli
    Dorico Righi
    Giovanni Gandini
    La radiologia medica, 2017, 122 : 713 - 721
  • [35] Incidence of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt (TIPS) according to its severity and temporal grading classification
    Fonio, Paolo
    Discalzi, Andrea
    Calandri, Marco
    Breatta, Andrea Doriguzzi
    Bergamasco, Laura
    Martini, Silvia
    Ottobrelli, Antonio
    Righi, Dorico
    Gandini, Giovanni
    RADIOLOGIA MEDICA, 2017, 122 (09): : 713 - 721
  • [36] Hepatic encephalopathy treatment after transjugular intrahepatic portosystemic shunt: a new perspective on the gut microbiota
    Xu, Xiaotong
    Zhu, Tong
    Jing, Changyou
    Jiang, Minjie
    Fu, Yunlai
    Xie, Fang
    Meng, Qinghua
    Li, Jianjun
    FRONTIERS IN MEDICINE, 2025, 12
  • [37] Long term impact of transjugular intrahepatic portosystemic shunt (TIPS) creation on hepatic morphology
    Gupta, Vikram F.
    Benvenuti, Teresa
    Ronald, James
    Cline, Brendan C.
    Befera, Nicholas T.
    Martin, Jonathan G.
    Pabon-Ramos, Waleska M.
    Sag, Alan A.
    Smith, Tony P.
    Suhocki, Paul V.
    Kim, Charles Y.
    CLINICAL IMAGING, 2024, 110
  • [38] Proton MR spectroscopy of neurometabolites in hepatic encephalopathy during L-ornithine-L-aspartate treatment - Results of a pilot study
    Delcker, A
    Turowski, B
    Mihm, U
    Raab, P
    Rusch, O
    Pilatus, U
    Zeuzem, S
    Zanella, FE
    METABOLIC BRAIN DISEASE, 2002, 17 (02) : 103 - 111
  • [39] Clinical Efficacy of L-Ornithine–L-Aspartate in the Management of Hepatic Encephalopathy
    G. Kircheis
    M. Wettstein
    S. vom Dahl
    D. Häussinger
    Metabolic Brain Disease, 2002, 17 : 453 - 462
  • [40] A model to predict early hepatic encephalopathy in patients undergoing transjugular intrahepatic portosystemic shunt
    Li, Yinglong
    He, Xiaofeng
    Pang, Huajin
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2019, 30 (08) : 702 - 707
12345